There is one summary for H.R.2113. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (04/20/2017)

Speeding Access to Already Approved Pharmaceuticals Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to facilitate the development and expedite the review of a new drug, biological product, or medical device that has been approved in the European Union.